Skip to content
Screener

Procter & Gamble PG Health Care — Acquisitions and divestitures

Similar metrics at other companies

CVS Health logo
CVSHealth Care Benefits — Health care costs
$30.69B-0.2%
Realty Income logo
OHealth Care — Land
$391.12M
Realty Income logo
OHealth Care — Buildings, Improvements and Acquisition Fees
$1.32B
Raytheon Technologies logo
RTXRaytheon — Acquisitions and Divestitures
-$207M
CVS Health logo
CVSHealth Services — Health care costs
$1.35B+22.6%
RFL
RFLHealth Care — Goodwill
$19.94M-29.5%

Other financials

Income statement

See full
Revenue$21.2B+1.5%
Gross profit$10.3B+0.2%
Operating income$3.9B-9.3%
Net income$3.0B-15.8%
EPS (diluted)$6.62+347%

Balance sheet

See full
Cash & equivalents$9.9B+4.0%
Total debt$22.8B-35.6%
Total assets$126.52B+1.0%

Cash flow

See full
Operating cash flow$5.1B+2.9%
CapEx$1.0B+2.7%
Free cash flow$4.1B+3.0%

Valuation

See full
Market cap$341.23B-4.7%
Enterprise value$354.13B-7.8%
P/E21.3×-1.1×
P/S3.9×-0.3×

Profitability

See full
Gross margin50.2%-1.0pp
Operating margin22.7%-1.6pp
Net margin18.4%-0.5pp
FCF margin17.4%+0.7pp

Returns & leverage

See full
Current ratio0.7×0.0×

Where this comes from

Reported directly by Procter & Gamble in its filing.

Tagged under the XBRL concept pg:GoodwillAcquisitionsandDivestitures.

The source filing: Procter & Gamble’s 10-Q, filed April 24, 2026.

Filed
Apr 24, 2026, 4:14 PM EDT
Fiscal quarter
Q3 FY2026
Calendar quarter
Q1 2026
Accession
0000080424-26-000060
Line itemBeautyGroomingHealth CareFabric & Home CareBaby, Feminine & Family CareTotal Company
GOODWILL AT JUNE 30, 2025$14,229$12,993$7,941$1,848$4,640$41,650
Acquisitions and divestitures4040
Translation and other(124)(85)(78)(9)(35)(330)
GOODWILL AT MARCH 31, 2026$14,105$12,908$7,902$1,840$4,605$41,359

Item 1. Financial Statements

FAQ

What is Procter & Gamble's health care — acquisitions and divestitures?
Procter & Gamble (PG) reported health care — acquisitions and divestitures of $40M in Q1 2026.
What does health care — acquisitions and divestitures mean?
This metric tracks the net impact of business combinations, asset purchases, and the sale of business units specifically within the Health Care operating segment. It reflects management's strategic efforts to reshape the portfolio by entering new therapeutic categories or exiting non-core assets to optimize long-term growth. Investors use this to understand how inorganic activity influences the segment's revenue and profit trajectory.

Ask your AI about Procter & Gamble's health care — acquisitions and divestitures.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude